Zobrazeno 1 - 10
of 180
pro vyhledávání: '"patatin-like phospholipase domain containing 3"'
Autor:
Alessandro Mantovani, Chiara Zusi
Publikováno v:
Exploration of Medicine, Vol 1, Iss 1, Pp 42-50 (2020)
Chronic kidney disease (CKD) is a disease regularly seen in clinical practice. At present, CKD is described as a change of kidney structure and/or function and it is classified in relation to cause, values of glomerular filtration rate and albuminuri
Externí odkaz:
https://doaj.org/article/712803f0df034a20bef6479bef265b95
Autor:
Amanda Medeiros Recuero, Larissa Garcia Gomes, Gustavo Arantes Rosa Maciel, Fernanda de Mello Malta, Ana Paula Moreira Salles, Denise Cerqueira Paranaguá Vezozzo, Edmund Chada Baracat, João Renato Rebello Pinho, Flair José Carrilho, José Tadeu Stefano, Claudia P. Oliveira
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2719 (2022)
Background: The aim of this study was to determine the frequency of the rs738409 polymorphism in the patatin-like phospholipase domain containing 3 (PNPLA3) gene in patients with polycystic ovary syndrome (PCOS) and its impact on nonalcoholic fatty l
Externí odkaz:
https://doaj.org/article/44f361806471476c8002435341f6f267
Autor:
Daniel F. Mazo, Fernanda M. Malta, Jose Tadeu Stefano, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Jazon R. Almeida, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira
Publikováno v:
Annals of Hepatology, Vol 18, Iss 3, Pp 466-471 (2019)
Introduction and aim: Studies have shown that two polymorphisms were associated with steatosis and progression of non-alcoholic fatty liver disease (NAFLD) in different populations: the Patatin-like Phospholipase Domain Containing 3 (PNPLA3) and Tran
Externí odkaz:
https://doaj.org/article/9511daed6fb4418bae6fbef648b86cf9
Autor:
Eleanna Stasinou, Elpida Emmanouilidou-Fotoulaki, Maria Kavga, Fotini Sotiriadou, Alexandros F. Lambropoulos, Maria Fotoulaki, Kyriaki Papadopoulou-Legbelou
Publikováno v:
Nutrients, Vol 14, Iss 17, p 3452 (2022)
Non-alcoholic fatty liver disease (NAFLD) shares several risk factors with atherosclerosis, as it is associated with components of the metabolic syndrome. However, genetic variations have also been linked to the risk of NAFLD, such as adiponutrin/pat
Externí odkaz:
https://doaj.org/article/822ea206df9642f58bc07dda49f7ef19
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xiao-Yan Pan, Wen-Yue Liu, Pei-Wu Zhu, Gang Li, Liang-Jie Tang, Feng Gao, Ou-Yang Huang, Hai-Yang Yuan, Giovanni Targher, Christopher D. Byrne, Xiao-Dong Wang, Ming-Hua Zheng
Publikováno v:
Hepatology International. 16:1085-1093
Although low skeletal muscle mass is associated with non-alcoholic fatty liver disease (NAFLD), it is currently uncertain whether there are associations between weight-adjusted appendicular skeletal muscle (ASM%), severity of histological features of
Publikováno v:
Gut and Liver, Vol 10, Iss 3, Pp 437-445 (2016)
Background/AimsIt is important to determine the noninvasive parameters of histological features in nonalcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the value of genetic variations as surrogate markers of histological
Externí odkaz:
https://doaj.org/article/eae2d7030a854af58b069301264d2af1
Autor:
Yoshio Sumida, Toshihide Shima, Yasuhide Mitsumoto, Takafumi Katayama, Atsushi Umemura, Kanji Yamaguchi, Yoshito Itoh, Masashi Yoneda, Takeshi Okanoue
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 12, p 4337 (2020)
Type 2 diabetes (T2D) is closely associated with nonalcoholic fatty liver disease (NAFLD). Nonalcoholic steatohepatitis (NASH), a severe form of NAFLD, can lead to cirrhosis, hepatocellular carcinoma (HCC), and hepatic decompensation. Patients with T
Externí odkaz:
https://doaj.org/article/29c8d1c077ef4730a0f53ce20e52298b